By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

IntelliPharmaCeutics 

30 Worcester Road

Toronto  Ontario  M9W 5X2  Canada
Phone: 416-798-3001 Fax: 416-798-3007


SEARCH JOBS


Industry
Biotechnology






Company News
IntelliPharmaCeutics Notes Launch Of 5mg Strength Of Focalin XR(R) Generic By Teva Pharmaceutical Industries Limited (TEVA) 11/20/2014 10:33:07 AM
IntelliPharmaCeutics Reports That The FDA Has Given Its Toronto Manufacturing Facility An "Acceptable" Classification 10/27/2014 7:48:06 AM
IntelliPharmaCeutics Reports Positive Results From A Series Of Phase I Clinical Trials Of Regabatin™ XR (Pregabalin Extended-Release) 10/23/2014 7:17:54 AM
IntelliPharmaCeutics Announces Third Quarter 2014 Results 10/16/2014 7:31:20 AM
IntelliPharmaCeutics Announces Resignation Of Chief Financial Officer 10/1/2014 7:49:18 AM
IntelliPharmaCeutics Augments Its Rexista™ Oxycodone Development Program With Novel Overdose Deterrence Technology 8/29/2014 8:35:04 AM
IntelliPharmaCeutics Announces Second Quarter 2014 Results 7/8/2014 6:17:31 AM
IntelliPharmaCeutics Files Preliminary Base Shelf Prospectus And Shelf Registration Statement 5/21/2014 9:45:01 AM
IntelliPharmaCeutics Announces First Quarter 2014 Results 4/14/2014 8:46:19 AM
IntelliPharmaCeutics—Amended Form Of Proxy For Shareholders Meeting To Be Held On March 27, 2014 3/20/2014 9:21:20 AM
123456789
//-->